株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

分子診断の世界市場予測 2021年:PCR・ハイブリダイゼーション・DNAシークエンシング・マイクロアレイ

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User. Product & Service (Reagent, Software) - Forecast to 2021

発行 MarketsandMarkets 商品コード 253279
出版日 ページ情報 英文 243 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.44円で換算しております。
Back to Top
分子診断の世界市場予測 2021年:PCR・ハイブリダイゼーション・DNAシークエンシング・マイクロアレイ Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User. Product & Service (Reagent, Software) - Forecast to 2021
出版日: 2017年02月02日 ページ情報: 英文 243 Pages
概要

世界の分子診断市場規模は、2016年から2021年にかけて9.1%のCAGR (年間複合成長率) で拡大し、2016年の65億4,000万米ドルから、2021年までに101億2,000万米ドルに達すると予測されています。感染症および各種癌の高い罹患率、バイオマーカー市場の成長および分子技術の進歩、ならびに米国における医療費償還制度改革は、分子診断市場の成長を促進する主要因となっています。ゲノミクス・プロテオミクスの進歩、ポイントオブケア (TOC) 検査の導入拡大、アジア太平洋の先進市場などは分子診断市場の企業へ収益性の高い機会を提供しています。

当レポートでは、世界の分子診断市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、アプリケーション・技術・製品&サービス・エンドユーザー・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 分子診断:市場概要
  • 分子診断市場規模:感染症タイプ別
  • 分子診断市場:技術・アプリケーション別
  • 分子診断市場規模:エンドユーザー別
  • 分子診断市場規模:製品・サービス別
  • 地域別の成長機会:分子診断市場

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 市場発展促進要因
    • 市場発展阻害要因
    • 市場機会
    • 課題

第6章 分子診断市場:アプリケーション別

  • イントロダクション
  • 感染症
    • クラミジア・トラコマチスおよび淋菌 (CT/NG)
    • B型肝炎
    • ヒトパピローマウイルス (HPV)
    • ヒト免疫不全ウイルス (HIV)
    • 結核 (TB)
    • C型肝炎
    • メチシリン耐性黄色ブドウ球菌 (MRSA)
    • その他
  • 腫瘍
    • 乳がん
    • 結腸直腸がん
    • 前立腺がん
    • その他
  • 血液検査
  • 遺伝
  • 微生物
  • その他

第7章 分子診断市場:技術別

  • イントロダクション
  • ポリメラーゼ連鎖反応 (PCR)
  • 等温核酸増幅技術 (INAAT)
  • ハイブリダイゼーション (in situハイブリダイゼーションおよび蛍光in situハイブリダイゼーション:FISH)
  • DNAシークエンシング・次世代シークエンシング
  • マイクロアレイ
  • その他の技術

第8章 分子診断市場:製品・サービス別

  • イントロダクション
  • 試薬 & キット
  • 器具
  • ソフトウェア & サービス

第9章 分子診断市場:エンドユーザー別

  • イントロダクション
  • 病院/大学ラボ
  • 参考検査室
  • その他のエンドユーザー

第10章 分子診断市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • その他欧州諸国 (ROE)
  • アジア太平洋
    • 日本
    • 中国
    • オーストラリア
    • インド
    • その他アジア諸国 (ROA)
  • その他地域 (ROW)
    • ラテンアメリカ
    • 中東・アフリカ

第11章 競合環境

  • 概要
  • 市場シェア分析
  • 分子診断市場の競合企業シェア分析:アプリケーション別
  • 分子診断市場の競合企業シェア分析:技術別
  • 新製品発売・認可
  • 合意、コラボレーションおよび提携
  • 買収
  • その他の動き

第12章 企業プロファイル (概要、製品・サービス、財務、戦略 & 発展動向)

  • イントロダクション
  • ABBOTT LABORATORIES
  • QIAGEN N.V.
  • ROCHE DIAGNOSTICS
  • HOLOGIC, INC.
  • GRIFOLS
  • SIEMENS HEALTHCARE
  • BECTON, DICKINSON AND COMPANY
  • BECKMAN COULTER INC. (WHOLLY OWNED SUBSIDIARY OF DANAHER CORPORATION)
  • BIOMERIEUX SA
  • CEPHEID INC

第13章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2521

The global molecular diagnostics market is projected to reach USD 10.12 billion by 2021 from USD 6.54 billion in 2016, at a CAGR of 9.1% from 2016 to 2021. High prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques; and reforms in the reimbursement system in the U.S. are the major factors driving the growth of the molecular diagnostics market. Advances in genomics and proteomics, increasing adoption of point-of-care testing, developing markets in Asia-Pacific such as China, India, Brazil, Mexico, and South Africa offer lucrative opportunities for players in the molecular diagnostics market.

The molecular diagnostics market is broadly segmented on the basis of technology, applications, products & services, and end user, and region. The major technologies studied in the report include PCR, INAAT, microarrays, hybridization, DNA sequencing, and Next- generation sequencing (NGS), and other technologies (electrophoresis, flow cytometry, and mass spectrometry). Among these technologies, PCR is expected to command the largest share and microarray segment is expected to be the highest growth segment.

ByOn the basis of products and & services, the molecular diagnostics market is segmented into instruments, reagents & kits, and services & software. The reagents and & kits market is expected to account for the largest share and highest CAGR of the molecular diagnostics market in 2016.

The molecular diagnostics market, by application, is classified into six segments, namely, infectious diseases, oncology, genetics, blood screening, microbiology, and other applications (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2016, followed by the blood screening and oncology segments.

Based on end users, the market is subsegmented into hospital & academic laboratories, reference laboratories, and other end users (blood banks, local public health laboratories, home health agencies, nursing homes, point- of- care settings, and self-testing). As most diagnostic tests are carried outperformed in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories. Hence, the segment will grow at a the fastest pace during the forecast period.

On the basis of region, North America is expected to account for the largest share of the global molecular diagnostics market in 2016, followed by Europe. The growth of the North American molecular diagnostics market is majorly driven by the factors such as the availability of government funds, growing applications of MDx in genetic disorders and cancer screening, and ease of use of self-monitoring techniques.

New and iInnovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:

From an insight perspective, tThis research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the molecular diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

From an insight perspective, thThis research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the molecular diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by the top players in the molecular diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research & developmentR&D activities, and new product launches in the molecular diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for molecular diagnostics products across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the molecular diagnostics market
  • Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the molecular diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. MOLECULAR DIAGNOSTICS MARKET, BY REGION
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key industry insights
    • 2.2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. MOLECULAR DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. MOLECULAR DIAGNOSTICS MARKET SIZE, BY TYPE OF INFECTIOUS DISEASE, 2016 VS. 2021
  • 4.3. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND APPLICATION
  • 4.4. MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021
  • 4.5. MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2016 VS. 2021
  • 4.6. GEOGRAPHIC GROWTH OPPORTUNITIES: MOLECULAR DIAGNOSTICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High prevalence of infectious diseases and various types of cancer
      • 5.2.1.2. Increasing awareness and acceptance of personalized medicine and companion diagnostics
      • 5.2.1.3. Growth in the biomarker identification market and advancements in molecular techniques
      • 5.2.1.4. Reforms in the reimbursement system in the U.S.
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Complex regulatory frameworks to delay approvals of new molecular diagnostic tests
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Advances in genomics and proteomics
      • 5.2.3.2. Increasing adoption of point-of-care testing
      • 5.2.3.3. Significant growth prospects in developing countries
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Dearth of trained professionals limiting the appropriate use of new molecular diagnostic technologies

6. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. INFECTIOUS DISEASES
    • 6.2.1. CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG)
    • 6.2.2. HEPATITIS B
    • 6.2.3. HUMAN PAPILLOMAVIRUS (HPV)
    • 6.2.4. HUMAN IMMUNODEFICIENCY VIRUS (HIV)
    • 6.2.5. TUBERCULOSIS (TB)
    • 6.2.6. HEPATITIS C
    • 6.2.7. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
    • 6.2.8. OTHER INFECTIOUS DISEASES
  • 6.3. ONCOLOGY
    • 6.3.1. BREAST CANCER
    • 6.3.2. COLORECTAL CANCER
    • 6.3.3. PROSTATE CANCER
    • 6.3.4. OTHER CANCERS
  • 6.4. BLOOD SCREENING
  • 6.5. GENETIC TESTS
  • 6.6. MICROBIOLOGY
  • 6.7. OTHER APPLICATIONS

7. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. POLYMERASE CHAIN REACTION (PCR)
  • 7.3. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
  • 7.4. HYBRIDIZATION (IN-SITU HYBRIDIZATION & FISH)
  • 7.5. DNA SEQUENCING AND NEXT-GENERATION SEQUENCING
  • 7.6. MICROARRAY
  • 7.7. OTHER TECHNOLOGIES

8. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES

  • 8.1. INTRODUCTION
  • 8.2. REAGENTS & KITS
  • 8.3. INSTRUMENTS
  • 8.4. SOFTWARE & SERVICES

9. MOLECULAR DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITAL AND ACADEMIC LABORATORIES
  • 9.3. REFERENCE LABORATORIES
  • 9.4. OTHER END USERS

10. MOLECULAR DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. ITALY
    • 10.3.4. SPAIN
    • 10.3.5. U.K.
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. AUSTRALIA
    • 10.4.4. INDIA
    • 10.4.5. REST OF ASIA-PACIFIC (ROAPAC)
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. LATIN AMERICA
      • 10.5.1.1. Brazil
      • 10.5.1.2. Mexico
      • 10.5.1.3. Rest of Latin America (RoLA)
    • 10.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. MOLECULAR DIAGNOSTICS MARKET COMPETITOR SHARE ANALYSIS, BY APPLICATION
    • 11.3.1. MARKET SHARE ANALYSIS FOR BLOOD SCREENING APPLICATIONS
    • 11.3.2. RANKING FOR MICROBIOLOGY APPLICATIONS
  • 11.4. MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY
    • 11.4.1. POLYMERASE CHAIN REACTION (PCR)
    • 11.4.2. DNA SEQUENCING AND NGS
    • 11.4.3. MICROARRAY
    • 11.4.4. HYBRIDIZATION (IN SITU AND FLUORESCENCE)
    • 11.4.5. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
  • 11.5. NEW PRODUCT LAUNCHES AND APPROVALS
  • 11.6. AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS
  • 11.7. ACQUISITIONS
  • 11.8. OTHER STRATEGIES

12. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1. INTRODUCTION
  • 12.2. ABBOTT LABORATORIES
  • 12.3. QIAGEN N.V.
  • 12.4. ROCHE DIAGNOSTICS
  • 12.5. HOLOGIC, INC.
  • 12.6. GRIFOLS
  • 12.7. SIEMENS HEALTHCARE
  • 12.8. BECTON, DICKINSON AND COMPANY
  • 12.9. BECKMAN COULTER INC. (A WHOLLY OWNED SUBSIDIARY OF DANAHER CORPORATION)
  • 12.10. BIOMERIEUX SA
  • 12.11. CEPHEID INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS
  • 13.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.6. AVAILABLE CUSTOMIZATIONS
  • 13.7. RELATED REPORTS
  • 13.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 2: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 3: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 4: EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 5: ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 6: ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 9: CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: CT/NG DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (MILLION ASSAYS)
  • TABLE 11: HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: HEPATITIS B DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (MILLION ASSAYS)
  • TABLE 13: HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: HPV DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (MILLION ASSAYS)
  • TABLE 15: HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (MILLION ASSAYS)
  • TABLE 17: TB DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: TB DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (MILLION ASSAYS)
  • TABLE 19: HEPATITIS C MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: HEPATITIS C MARKET SIZE, BY REGION, 2014-2021 (MILLION ASSAYS)
  • TABLE 21: MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: MRSA DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (MILLION ASSAYS)
  • TABLE 23: OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: EUROPE: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: ASIA-PACIFIC: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: ROW: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: LATIN AMERICA: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: ONCOLOGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 31: BREAST CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: COLORECTAL CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: OTHER CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: BLOOD SCREENING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: ASIA-PACIFIC: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: ROW: BLOOD SCREENING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: LATIN AMERICA: BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: GENETIC TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: EUROPE: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: ASIA-PACIFIC: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: ROW: GENETIC TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: LATIN AMERICA: GENETIC TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: MICROBIOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: ASIA-PACIFIC: MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: ROW: MICROBIOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: LATIN AMERICA: MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: ROW: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58: LATIN AMERICA: OTHER MOLECULAR DIAGNOSTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 60: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 71: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 72: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 76: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 77: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HYBRIDIZATION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 78: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 79: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 81: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 82: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 83: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING AND NGS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 84: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 85: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 87: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 88: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 89: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 90: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 91: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 92: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 93: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 94: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 95: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 96: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
  • TABLE 97: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 98: NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 99: EUROPE: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 100: ASIA-PACIFIC: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 101: ROW: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 102: LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 103: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 104: NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 105: EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 106: ASIA-PACIFIC: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 107: ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 108: LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 109: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 110: NORTH AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 111: EUROPE: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 112: ASIA-PACIFIC: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 113: ROW: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 114: LATIN AMERICA: MOLECULAR DIAGNOSTIC SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 115: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 116: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 117: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 118: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 119: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 120: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 121: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR HOSPITAL AND ACADEMIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 122: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 123: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 124: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 125: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 126: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 127: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 128: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 129: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 130: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 131: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 132: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 133: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 134: MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 135: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 136: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 137: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 138: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 139: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 140: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 141: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 142: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 143: U.S.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 144: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 145: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 146: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 147: CANADA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 148: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 149: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 150: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 151: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 152: EUROPE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 153: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 154: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 155: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 156: GERMANY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 157: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 158: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 159: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 160: FRANCE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 161: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 162: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 163: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 164: ITALY: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 165: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 166: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 167: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 168: SPAIN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 169: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 170: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 171: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 172: U.K.: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 173: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 174: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 175: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 176: ROE: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 177: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 178: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 179: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 180: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 181: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 182: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 183: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 184: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 185: JAPAN: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 186: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 187: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 188: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 189: CHINA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 190: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 191: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 192: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 193: AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 194: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 195: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 196: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 197: INDIA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 198: ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 199: ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 200: ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 201: ROAPAC: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 202: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 203: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 204: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 205: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 206: ROW: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 207: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 208: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 209: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 210: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 211: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 212: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 213: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 214: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 215: BRAZIL: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 216: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 217: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 218: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 219: MEXICO: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 220: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 221: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 222: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 223: ROLA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 224: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 225: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 226: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 227: MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 228: NEW PRODUCT LAUNCHES AND APPROVALS, 2013-2016
  • TABLE 229: AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS, 2013-2016
  • TABLE 230: ACQUISITIONS, 2014-2016
  • TABLE 231: OTHER STRATEGIES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MOLECULAR DIAGNOSTICS MARKET: TOP-DOWN APPROACH
  • FIGURE 3: MOLECULAR DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT (2016 VS. 2021)
  • FIGURE 7: MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE, 2016 VS. 2021
  • FIGURE 8: MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021
  • FIGURE 9: MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 VS. 2021
  • FIGURE 10: MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 12: RISING PREVALENCE OF INFECTIOUS DISEASES & CANCER TO DRIVE MARKET GROWTH
  • FIGURE 13: MRSA TO BE THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 14: INFECTIOUS DISEASES SEGMENT TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET IN 2016
  • FIGURE 15: HOSPITALS & ACADEMIC LABORATORIES WILL CONTINUE TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET IN 2021
  • FIGURE 16: REAGENTS & KITS TO GROW AT THE HIGHEST RATE BETWEEN 2016 & 2021
  • FIGURE 17: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 18: MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND THREATS
  • FIGURE 19: GROWTH IN THE NUMBER OF PEOPLE LIVING WITH HIV IN 2010 AND 2015 (MILLIONS)
  • FIGURE 20: INFECTIOUS DISEASES SEGMENT TO DOMINATE THE MOLECULAR DIAGNOSTIC APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: PCR TO DOMINATE THE MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: REAGENTS & KITS TO FORM THE LARGEST SEGMENT OF THE MOLECULAR DIAGNOSTICS MARKET IN 2016
  • FIGURE 23: HOSPITAL AND ACADEMIC LABORATORIES-THE MAJOR END USERS OF MOLECULAR DIAGNOSTICS
  • FIGURE 24: ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION IN THE MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 25: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 26: GERMANY, THE DOMINANT COUNTRY IN THE EUROPEAN MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 27: JAPAN WILL CONTINUE TO LEAD THE ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET
  • FIGURE 28: ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 29: LATIN AMERICA WILL CONTINUE TO LEAD THE ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 30: BRAZIL TO COMMAND THE LARGEST SHARE OF THE LATIN AMERICAN MOLECULAR DIAGNOSTICS MARKET IN 2021
  • FIGURE 31: PRODUCT LAUNCHES AND APPROVALS: KEY STRATEGIES ADOPTED IN THE LAST THREE YEARS
  • FIGURE 32: GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 33: GLOBAL BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 34: GLOBAL MICROBIOLOGY, KEY PLAYER RANKING, 2014
  • FIGURE 35: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 36: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 37: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 38: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, KEY PLAYER RANKING, 2015
  • FIGURE 39: GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR INAAT, KEY PLAYER RANKING, 2015
  • FIGURE 40: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES AND APPROVALS WAS THE KEY GROWTH STRATEGY
  • FIGURE 41: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 42: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015)
  • FIGURE 43: QIAGEN N.V.: COMPANY SNAPSHOT (2015)
  • FIGURE 44: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2015)
  • FIGURE 45: HOLOGIC, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 46: GRIFOLS: COMPANY SNAPSHOT (2015)
  • FIGURE 47: SIEMENS HEALTHCARE: COMPANY SNAPSHOT (2016)
  • FIGURE 48: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 49: DANAHER CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 50: BIOMERIEUX: COMPANY SNAPSHOT (2015)
  • FIGURE 51: CEPHEID INC.: COMPANY SNAPSHOT (2015)
Back to Top